Citation: Cs. Cook et al., MECHANISM OF COMPOUND-SPECIFIC AND SPECIES-SPECIFIC FOOD EFFECTS OF STRUCTURALLY RELATED ANTIARRHYTHMIC DRUGS, DISOPYRAMIDE AND BIDISOMIDE, Pharmaceutical research, 15(3), 1998, pp. 429-433
Citation: Kh. Lee et al., MECHANISMS OF FOOD EFFECTS OF STRUCTURALLY RELATED ANTIARRHYTHMIC DRUGS, DISOPYRAMIDE AND BIDISOMIDE IN THE RAT, Pharmaceutical research, 14(8), 1997, pp. 1030-1038
Authors:
YUAN JH
STOLZENBACH JC
SALAMON CM
SNOOK SS
SCHOENHARD GL
Citation: Jh. Yuan et al., IMPROVEMENT OF BIOAVAILABILITY OF THE HIV PROTEASE INHIBITOR SC-52151IN THE BEAGLE DOG BY COADMINISTRATION OF THE CYP3A4 INHIBITOR, KETOCONAZOLE, Xenobiotica, 27(5), 1997, pp. 489-497
Authors:
COOK CS
KARABATSOS PJ
SCHOENHARD GL
KARIM A
Citation: Cs. Cook et al., SPECIES-DEPENDENT ESTERASE-ACTIVITIES FOR HYDROLYSIS OF AN ANTI-HIV PRODRUG GLYCOVIR AND BIOAVAILABILITY OF ACTIVE SC-48334, Pharmaceutical research, 12(8), 1995, pp. 1158-1164
Authors:
COOK CS
AMES GB
HRIBAR JD
LIU NWK
SWEENEY DL
SCHOENHARD GL
KARIM A
Citation: Cs. Cook et al., METABOLISM OF A NOVEL ANTIARRHYTHMIC AGENT, BIDISOMIDE, IN MAN - USE OF HIGH-RESOLUTION MASS-SPECTROMETRY TO DISTINGUISH DESISOPROPYL BIDISOMIDE FROM DESACETYL BIDISOMIDE, Xenobiotica, 25(9), 1995, pp. 981-991
Citation: Cs. Cook et al., EFFECT OF SALICYLIC-ACID ON THE PLASMA-PROTEIN BINDING AND PHARMACOKINETICS OF MISOPROSTOL ACID, Journal of pharmaceutical sciences, 83(6), 1994, pp. 883-886
Authors:
COOK CS
HAUSWALD C
OPPERMANN JA
SCHOENHARD GL
Citation: Cs. Cook et al., INVOLVEMENT OF CYTOCHROME P-450IIIA IN METABOLISM OF POTASSIUM-CANRENOATE TO AN EPOXIDE - MECHANISM OF INHIBITION OF THE EPOXIDE FORMATION BY SPIRONOLACTONE AND ITS SULFUR-CONTAINING METABOLITE, The Journal of pharmacology and experimental therapeutics, 266(1), 1993, pp. 1-7